Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Plenty of reasons to remain positive on Euromoney

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Our ‘buy’ call on media group Euromoney Institutional Investor (ERM) is off to a shaky start, but the better-than-expected set of full year results published on 18 November include reasons to stay positive.
Concern over how mounting Covid cases might impact a recovery in its events business may be behind some of the recent weakness in the share price.
However, the latest results covering 12 months to 30 September saw Euromoney report a 13% rise in adjusted pre-tax profit to £61.4 million, ahead of a consensus forecast of £58.5 million. In a similar vein, the total dividend distribution of 18.2p per share was up 60% on the prior year and exceeded a consensus estimate of 17.1p.
Consultancy Megabuyte commented: ‘A better-than-expected second half performance underlines the increasing demand for its data, analysis and intelligence in key markets.
‘We also expect Euromoney to continue to bolt on subscription-based businesses in line with its 3.0 growth strategy (embedded in workflows, core target industry and solution-centric).
‘Positively, the outlook has notably improved, although with an air of caution around events in the short term.’
SHARES SAYS: You’ll need to be patient with Euromoney. The shares are still a buy.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.